Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma
Clinical trial NCT03316274 · COMPLETED
Trial details
- NCT number
- NCT03316274
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-07
- Primary completion
- 2021-06-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.